Clinical trial
Two Studies to Determine if Verteporfin PDT is Effective & Safe in Treating…
NCT00049959 · QLT Inc., Industry · Terminated
Key facts
| NCT number | NCT00049959 |
|---|---|
| Title | Two Studies to Determine if Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of the Skin. |
| Official title | A Randomized, Placebo-Controlled, Masked, Multicenter Phase III Study Of Photodynamic Therapy With Verteporfin For Injection (VFI) For The Treatment Of Multiple Basal Cell Carcinoma |
| Lead sponsor | QLT Inc., Industry |
| Collaborators | Novartis Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Basal Cell Carcinoma, Nevoid Basal Cell Carcinoma Syndrome, Gorlin Syndrome |
| Intervention type | Drug |
| Interventions | verteporfin PDT |
| Primary completion | Mar 1, 2004 |
| Completion | Mar 1, 2004 |
| First posted | Nov 19, 2002 |
| Last update posted | Mar 16, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: